What is the Value of Testing for Molecular Markers in Advanced NSCLC? episode artwork

EPISODE · Oct 15, 2015 · 1 MIN

What is the Value of Testing for Molecular Markers in Advanced NSCLC?

from GRACEcast · host cancerGRACE Meetings

Memorial Sloan-Kettering Cancer Center medical oncologist Dr. Greg Riely explains how testing for specific mutations in patients with advanced NSCLC can guide prognosis and treatment recommendations.

Episode metadata supplied by the publisher feed · Published Oct 15, 2015

Embed this episode

NOW PLAYING

What is the Value of Testing for Molecular Markers in Advanced NSCLC?

0:00 1:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 1 minute long.

When was this GRACEcast episode published?

This episode was published on October 15, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!